LU70852A1 - - Google Patents
Info
- Publication number
- LU70852A1 LU70852A1 LU70852A LU70852A LU70852A1 LU 70852 A1 LU70852 A1 LU 70852A1 LU 70852 A LU70852 A LU 70852A LU 70852 A LU70852 A LU 70852A LU 70852 A1 LU70852 A1 LU 70852A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU70852A1 true LU70852A1 (sv) | 1975-06-11 |
Family
ID=20318423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU70852A LU70852A1 (sv) | 1973-09-04 | 1974-09-04 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (sv) |
| JP (1) | JPS5835177B2 (sv) |
| AT (1) | AT336566B (sv) |
| BE (1) | BE819515A (sv) |
| CA (1) | CA1051436A (sv) |
| CH (2) | CH603547A5 (sv) |
| DE (1) | DE2440734C2 (sv) |
| DK (1) | DK139716B (sv) |
| FI (1) | FI62281C (sv) |
| FR (1) | FR2242079B1 (sv) |
| GB (1) | GB1461667A (sv) |
| HK (1) | HK75778A (sv) |
| IE (1) | IE40514B1 (sv) |
| LU (1) | LU70852A1 (sv) |
| NL (1) | NL7411753A (sv) |
| NO (2) | NO139408C (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
| TWI291871B (en) * | 2000-11-01 | 2008-01-01 | Cognition Pharmaceuticals Llc | Pharmaceutical compositions and use of amphetamine compounds for improving memory and learning |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5835177B2 (ja) | 1983-08-01 |
| FR2242079B1 (sv) | 1978-07-21 |
| FR2242079A1 (sv) | 1975-03-28 |
| ATA702574A (de) | 1976-09-15 |
| DK139716B (da) | 1979-04-02 |
| NO139408B (no) | 1978-11-27 |
| FI62281B (fi) | 1982-08-31 |
| IE40514L (en) | 1975-03-04 |
| CA1051436A (en) | 1979-03-27 |
| IE40514B1 (en) | 1979-06-20 |
| CH603547A5 (sv) | 1978-08-31 |
| NO743177L (sv) | 1975-04-01 |
| AU7283374A (en) | 1976-03-04 |
| NO139408C (no) | 1979-03-07 |
| AT336566B (de) | 1977-05-10 |
| DK139716C (sv) | 1979-09-17 |
| FI257674A (sv) | 1975-03-05 |
| GB1461667A (en) | 1977-01-19 |
| DE2440734A1 (de) | 1975-03-13 |
| CH599106A5 (sv) | 1978-05-12 |
| BE819515A (fr) | 1975-03-04 |
| NL7411753A (nl) | 1975-03-06 |
| JPS5050329A (sv) | 1975-05-06 |
| HK75778A (en) | 1979-01-05 |
| NO791507L (no) | 1975-03-05 |
| NO142624C (no) | 1980-09-17 |
| FI62281C (fi) | 1982-12-10 |
| NO142624B (no) | 1980-06-09 |
| DE2440734C2 (de) | 1985-01-24 |
| DK464774A (sv) | 1975-05-05 |
| US3996381A (en) | 1976-12-07 |